GeoVax Labs Inc (GOVX)vsInsmed Inc (INSM)
GOVX
GeoVax Labs Inc
$1.50
-2.60%
HEALTHCARE · Cap: $3.27M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 17983% more annual revenue ($606.42M vs $3.35M). GOVX leads profitability with a 0.0% profit margin vs -2.1%. GOVX earns a higher WallStSmart Score of 43/100 (D).
GOVX
Hold43
out of 100
Grade: D
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
No standout strengths identified
Areas to Watch
1.8% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : GOVX
The strongest argument for GOVX centers on Price/Book.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : GOVX
The primary concerns for GOVX are Revenue Growth, EPS Growth, Market Cap.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
GOVX profiles as a value stock while INSM is a turnaround play — different risk/reward profiles.
GOVX carries more volatility with a beta of 3.88 — expect wider price swings.
GOVX is growing revenue faster at 1.8% — sustainability is the question.
GOVX generates stronger free cash flow (-6M), providing more financial flexibility.
Bottom Line
GOVX scores higher overall (43/100 vs 39/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
GeoVax Labs Inc
HEALTHCARE · BIOTECHNOLOGY · USA
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?